USPTO serial 88219878
SIBREAX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 7, 2020
- Examiner
- FOSDICK, GEOFFREY A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with SIBREAX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Kilchberg ZH, CH
Kilchberg ZH, CH
Kilchberg ZH, CH
Kilchberg ZH, CH
Kilchberg ZH, CH
Kilchberg ZH, CH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Claudia Stangle
Claudia Stangle Leydig, Voit & Mayer, Ltd.Two Prudential Plaza, 180 N. Stetson AveSuite 4900Chicago, IL 60601-6745Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for use in industry; chemical preparations for scientific purposes; chemical preparations for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; chemical preparations for preventing and treating pathogenic infections in plants; biochemicals for in vitro and in vivo scientific use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; chemical additives for use in the manufacture of cosmetics; diagnostic preparations, other than for medical or veterinary purposes; diagnostic preparations for scientific and research use; catalysts for chemical and biochemical processes; silica gel | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical preparations for the treatment of cancer, respiratory diseases, liver borne diseases, or for regulation of the immune system; veterinary preparations for the treatment of cancer, for the regulation of the immune system, or for preventing parasites; fungicides, herbicides; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; antibacterial pharmaceuticals; antibiotic preparations; pharmaceutical preparations for the treatment of diseases involving the central nervous system; surgical glues; medical diagnostic reagents; gels for medical or veterinary use, namely, hydrogels for medical or veterinary use, namely for wound healing, wound closure, or surgical applications; galenic formulations for pharmaceutical preparations for the treatment of cancer, respiratory diseases, liver borne diseases, or for regulation of the immune system; insecticides; anti-tumor drugs; pharmaceutical preparations for the treatment of infectious diseases; antiparasitic preparations; pesticides; drug delivery agents in the form of nanoparticles, microparticles, or hydrogels that facilitate the delivery of pharmaceutical preparations; therapeutic medicines and agents for the treatment of cancer, respiratory diseases, liver borne diseases, or for regulation of the immune system | SECTION 8 - CANCELLED | — |
| 042 | Scientific and technological services, namely, research and design in the field of chemistry, biochemistry, biotechnology, pharmaceuticals, cosmetics, or medical technology; testing, analysis and evaluation of goods or services of others in the field of chemistry, biochemistry, biotechnology, pharmaceuticals, cosmetics, or medical technology; agrochemical research services; consultancy in the field of scientific and industrial research; consultancy in the field of pharmaceutical research; product design and development of medical technology; scientific research and new product development services in the field of chemistry; scientific research and new product development services in the field of diagnostic preparations; scientific research and new product development services for the pharmaceutical industry; scientific laboratory research and analysis in the field of chemistry, biochemistry, biotechnology, pharmaceuticals, cosmetics, or medical technology; pharmaceutical research and development; scientific and industrial research in the field of chemistry, biochemistry, biotechnology, pharmaceuticals, cosmetics, or medical technology | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SiBreaX AG
- Other trademarks owned by SiBreaX AG
- Other trademarks owned by SiBreaX AG
- Other trademarks owned by SiBreaX AG
- Other trademarks owned by SiBreaX AG
- Other trademarks owned by SiBreaX AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named SIBREAX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 17, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 7, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 3, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 3, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 3, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jun 3, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 3, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 2, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 2, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 2, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 2, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 7, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 22, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 22, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 2, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 18, 2019 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Sep 13, 2019 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Sep 9, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 9, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 9, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 9, 2019 | ALIE | ASSIGNED TO LIE | — |
| Sep 3, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 8, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 8, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 6, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 28, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 10, 2018 | NWAP | NEW APPLICATION ENTERED | — |